"There's a true cost in human life to the delays in getting drugs approved."
That urgency ran through every room on Oct. 15 at #AlignSummit26.
For more video, visit #MBVision - mbvision.massbio.org/Channel…
Treasury’s proposed rule adding biotech to the COINS outbound investment regime is a major moment for our industry, and MassBio is in the conversation. Thanks to @WSJ Pro’s Brian Gormley for including our perspective: wsj.com/pro/venture-capital/…
Months into an AI rollout, the scientists and clinicians it was built for are still working around it. Sound familiar?
Read this new guest perspective from Craig Wylie of @adlittle - one of our partners at R&D Reimagined on 11/2: massbio.org/news/recent-news…
Our #MassBioMembers came out to celebrate Oktoberfest last night.🥨Thank you for attending and making it a great event!
📸 View event photos: flic.kr/s/aHBqjD8iFQ
Missed this one? Join us at an upcoming member event: massbio.org/events/
"Precision medicine, early detection. They found it, and they knew what to do with it. And I’m here today as an example of hope." At the #WomensHealth26 Symposium, Katie Torrence shared her story with pancreatic cancer at 53: massbio.org/news/recent-news…
We're still buzzing about last week's #AlignSummit26!
With hundreds of attendees, the Massachusetts life sciences ecosystem showed up for big ideas, bold innovation, and connections that move biotech forward.
📸Take a look at some moments from the event: flic.kr/s/aHBqjD7Zy2
Christina Codden at @elevatebio explains how the automated infrastructure that next-gen sequencing teams built to manage massive genomic datasets can be applied across biotech, from cell and gene therapy manufacturing to vaccine development.
Read more: massbio.org/news/recent-news…
At #AlignSummit26, Errik Anderson shared how his father died before accessing a promising PD-1 therapy.
Every day a treatment waits is a day some patients don't have. Accelerating access while upholding FDA's gold standard is critical.
Thank you, Errik. #PatientDriven
That's a wrap on #AlignSummit26! 🧬
55 emerging companies, buzzing partnering rooms, and candid conversations on pharma, dealmaking, and policy.
Thank you to everyone who joined us! Here's to turning today's connections into tomorrow's breakthroughs. #PatientDriven
MassBio retweeted
𝐀𝐥𝐢𝐠𝐧 𝐒𝐮𝐦𝐦𝐢𝐭 𝟐𝟎𝟐𝟔: Natick based MelliCell is targeting MNK (MAPK-interacting kinase), a genetic switch that could make a difference in fragile X syndrome and beyond.
Full video: biotechtv.com/post/align-sum…
“An idea that starts in Massachusetts won’t automatically be built here.”
As #AlignSummit26 kicked off, MassBio CEO & President Kendalle Burlin O’Connell emphasized the importance of early engagement to keep biomedical innovation growing in the U.S.
Follow along for more!
What does it take to turn a biotech partnership into meaningful innovation for patients?
Join MassBio and Otsuka on October 28 in the MassBioHub for Otsuka Day, an afternoon of insights, discussion, and networking: massbio.org/news/recent-news…
#MassBioMember Spotlight: Zealand Pharma is a biotechnology company transforming metabolic health so millions of people can live without limits.
Read more: massbio.org/news/recent-news…
🤖 Made with AI
Our #AlignSummit26 is next Thursday, 10/15, and we can't wait! A few tickets remain if you haven't secured your spot: massbio.org/events/align-sum…
We are so grateful to all of our sponsors supporting this year's event.
Today, MassBio and the @MAWomensCaucus hosted our 2026 Women's Health Symposium, focused on pancreatic cancer innovation among women. The day's message was one of great hope for a disease that was once much bleaker, even just 5 years ago. #PatientDriven
On October 28, @OtsukaUS and MassBio are bringing the biotech community together for Otsuka Day. Connect with biotech leaders and investors, gain insight into Otsuka’s scientific and partnership priorities, and explore collaboration - apply to attend: massbio.org/events/2026-otsu…
#MassBioMember Spotlight: Unravel Biosciences is a clinical-stage biotech company whose Agile Medicine approach brings patients into drug discovery from the start, using individual patient RNA to power AI-enabled therapeutic mechanism discovery. Read more: massbio.org/news/recent-news…
Changes in Washington are having real implications for how life sciences companies raise capital, advance new therapies, and fund research. Join the conversation on October 15 at #AlignSummit26 - massbio.org/events/align-sum…
MassBio and the @MAWomensCaucus will co-host on October 1 the 2026 Women's Health Symposium - open this year to all #MassBioMembers.
Register to hear from the following speakers on how they are turning women's pancreatic cancer visibility into action: massbio.org/events/womens-he…



























